These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 33782133

  • 1. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.
    Chapman NS, Zhao H, Kose N, Westover JB, Kalveram B, Bombardi R, Rodriguez J, Sutton R, Genualdi J, LaBeaud AD, Mutuku FM, Pittman PR, Freiberg AN, Gowen BB, Fremont DH, Crowe JE.
    Proc Natl Acad Sci U S A; 2021 Apr 06; 118(14):. PubMed ID: 33782133
    [Abstract] [Full Text] [Related]

  • 2. Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus.
    Wang Q, Ma T, Wu Y, Chen Z, Zeng H, Tong Z, Gao F, Qi J, Zhao Z, Chai Y, Yang H, Wong G, Bi Y, Wu L, Shi R, Yang M, Song J, Jiang H, An Z, Wang J, Yilma TD, Shi Y, Liu WJ, Liang M, Qin C, Gao GF, Yan J.
    Nat Microbiol; 2019 Jul 06; 4(7):1231-1241. PubMed ID: 30936489
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein.
    Hao M, Zhang G, Zhang S, Chen Z, Chi X, Dong Y, Fan P, Liu Y, Chen Y, Song X, Liu S, Yu C, Li J, Xia X.
    Viruses; 2020 Feb 27; 12(3):. PubMed ID: 32120864
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
    López-Gil E, Lorenzo G, Hevia E, Borrego B, Eiden M, Groschup M, Gilbert SC, Brun A.
    PLoS Negl Trop Dis; 2013 Feb 27; 7(7):e2309. PubMed ID: 23875044
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
    Faburay B, Lebedev M, McVey DS, Wilson W, Morozov I, Young A, Richt JA.
    Vector Borne Zoonotic Dis; 2014 Oct 27; 14(10):746-56. PubMed ID: 25325319
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production.
    Bracci N, de la Fuente C, Saleem S, Pinkham C, Narayanan A, García-Sastre A, Balaraman V, Richt JA, Wilson W, Kehn-Hall K.
    Virology; 2022 Feb 27; 567():65-76. PubMed ID: 35032865
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.
    Tercero B, Narayanan K, Terasaki K, Makino S.
    J Virol; 2021 Jun 24; 95(14):e0042921. PubMed ID: 33952635
    [Abstract] [Full Text] [Related]

  • 14. A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection.
    Ren X, Sun J, Kuang W, Yu F, Wang B, Wang Y, Deng W, Xu Z, Yang S, Wang H, Hu Y, Deng Z, Ning YJ, Zhao H.
    Nat Commun; 2024 Aug 15; 15(1):7009. PubMed ID: 39147753
    [Abstract] [Full Text] [Related]

  • 15. Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope.
    Wu Y, Zhu Y, Gao F, Jiao Y, Oladejo BO, Chai Y, Bi Y, Lu S, Dong M, Zhang C, Huang G, Wong G, Li N, Zhang Y, Li Y, Feng WH, Shi Y, Liang M, Zhang R, Qi J, Gao GF.
    Proc Natl Acad Sci U S A; 2017 Sep 05; 114(36):E7564-E7573. PubMed ID: 28827346
    [Abstract] [Full Text] [Related]

  • 16. Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
    Bhardwaj N, Heise MT, Ross TM.
    PLoS Negl Trop Dis; 2010 Jun 22; 4(6):e725. PubMed ID: 20582312
    [Abstract] [Full Text] [Related]

  • 17. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
    Zhang S, Hao M, Feng N, Jin H, Yan F, Chi H, Wang H, Han Q, Wang J, Wong G, Liu B, Wu J, Bi Y, Wang T, Sun W, Gao Y, Yang S, Zhao Y, Xia X.
    Viruses; 2019 Oct 08; 11(10):. PubMed ID: 31597372
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
    Gutjahr B, Keller M, Rissmann M, von Arnim F, Jäckel S, Reiche S, Ulrich R, Groschup MH, Eiden M.
    PLoS Negl Trop Dis; 2020 Mar 08; 14(3):e0008143. PubMed ID: 32160203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.